Barclays lowered the firm’s price target on CVS Health to $86 from $89 and keeps an Overweight rating on the shares post the “modest” Q2 beat.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVS:
- 3 Best Stocks to Buy Now, 8/3/2023, According to Top Analysts
- CVS Health Corp Reports Earnings: Did it Beat Estimate Forecasts?
- CVS Health (NYSE:CVS): Collect Healthy Dividends with This Stock
- Unusually active option classes on open August 2nd
- CVS Health expects over $600M in savings in 2024 from restructuring